Skip to main content

Go Premium in Our Biggest Sale Ever

UPGRADE NOW
TipRanks
Go Ultimate75% OFF

PELL Bio-Med Technology Co Ltd (6949) Financial Statements

PELL Bio-Med Technology Co Ltd Financial Overview

PELL Bio-Med Technology Co Ltd's market cap is currently NT$54.47B. The company's EPS TTM is NT$-0.36; its P/E ratio is -138.20; PELL Bio-Med Technology Co Ltd has not announced its next earnings date. See an overview of income statement, balance sheet, and cash flow financials.

Financial overview
Dec 25Dec 24Dec 23Dec 22Dec 21
Income Statement
Total RevenueNT$ 31.42MNT$ 19.63MNT$ 18.03MNT$ 17.16MNT$ 13.98M
Gross ProfitNT$ -4.39MNT$ -12.33MNT$ -26.14MNT$ -42.30MNT$ -34.53M
Operating IncomeNT$ -467.35MNT$ -413.50MNT$ -411.25MNT$ -236.11MNT$ -195.96M
EBITDANT$ -420.23MNT$ -346.09MNT$ -353.18MNT$ -198.87MNT$ -157.29M
Net IncomeNT$ -423.94MNT$ -389.42MNT$ -398.76MNT$ -230.13MNT$ -188.96M
Balance Sheet
Cash & Short-Term InvestmentsNT$ 1.31BNT$ 1.14BNT$ 1.11BNT$ 708.40MNT$ 115.78M
Total AssetsNT$ 2.11BNT$ 1.74BNT$ 1.42BNT$ 1.04BNT$ 393.89M
Total DebtNT$ 237.40MNT$ 364.84MNT$ 172.56MNT$ 202.78MNT$ 141.06M
Net DebtNT$ -69.30MNT$ -62.53MNT$ 4.88MNT$ 30.38MNT$ 25.27M
Total LiabilitiesNT$ 418.27MNT$ 458.62MNT$ 236.76MNT$ 229.79MNT$ 169.02M
Stockholders' EquityNT$ 1.42BNT$ 1.18BNT$ 1.17BNT$ 800.94MNT$ 224.86M
Cash Flow
Free Cash FlowNT$ -508.89MNT$ -524.10MNT$ -196.47MNT$ -164.17MNT$ -122.99M
Operating Cash FlowNT$ -281.29MNT$ -260.12MNT$ -179.99MNT$ -155.68MNT$ -108.51M
Investing Cash FlowNT$ -497.14MNT$ -95.51MNT$ -419.63MNT$ -535.97MNT$ 83.90M
Financing Cash FlowNT$ 657.76MNT$ 615.32MNT$ 594.89MNT$ 748.27MNT$ -4.56M

Currency in TWD

PELL Bio-Med Technology Co Ltd Earnings and Revenue History

-500M-250M0250M-2400 %-2000 %-1600 %-1200 %EarningsProfit Margin20212022202320242025RevenueEarningsProfit Margin
Income Statement >

PELL Bio-Med Technology Co Ltd Liabilities to Assets

0800M1.6B2.4B12 %24 %36 %48 %LiabilitiesLiabilities to Assets20212022202320242025AssetsLiabilitiesLiabilities to Assets
Balance Sheet >

PELL Bio-Med Technology Co Ltd Cash Flow

-750M-500M-250M0250M500M750M1B20212022202320242025OperatingInvestingFinancing
Cash Flow >

PELL Bio-Med Technology Co Ltd Forecast EPS vs Actual EPS

-0.1-0.1-0.1-0.1-0.10Q2 25Q3 25Q4 25Q1 26Q2 26Q3 26EPS EstimateBeatMiss
Earnings >